Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CytRx's aldoxorubicin shows further positive interim data in Phase 2b trial
The Fly on the Wall
Thursday, October 31, 2013 - 11:21am
tags:
CytRx, aldoxorubicin, soft tissue sarcomas
EntreMed commences ENMD-2076 Phase 2 trial
The Fly on the Wall
Thursday, October 31, 2013 - 11:16am
tags:
ENMD-2076, EntreMed, ovarian cancer
DOJ wants info from AstraZeneca about heart drug study
Bizjournals.com
Thursday, October 31, 2013 - 10:15am
tags:
DOJ, AstraZeneca, Brilinta
Pfizer Vs. Novartis: A New Era In Breast Cancer Treatment
Seeking Alpha
Thursday, October 31, 2013 - 9:38am
tags:
Pfizer, Novartis, breast cancer, palbociclib, LEE011
Dr. Reddy’s Q2 & H1 FY14 Financial Results
Yahoo
Thursday, October 31, 2013 - 9:33am
tags:
Dr Reddy's, earnings
Teva Pharm Q3 profit, revenue top estimates
Yahoo/Reuters
Thursday, October 31, 2013 - 8:58am
tags:
Teva Pharmaceuticals, earnings
Teva gets approval from FDA for phase 3 heart failure trial
The Fly on the Wall
Thursday, October 31, 2013 - 8:58am
tags:
Teva, Mesoblast, FDA, congestive heart failure, Mesenchymal Precursor Cells
Array Biopharma Outlines Path To Market For New Myeloma Drug
Forbes
Thursday, October 31, 2013 - 8:56am
tags:
Multiple Myeloma, Array Biopharma, ARRY-520, Kyprolis
Canada's Valeant posts loss, cuts 2013 sales forecast
Yahoo/Reuters
Thursday, October 31, 2013 - 8:52am
tags:
Valeant Pharmaceuticals, earnings
Merrimack - Not Bad News?
Seeking Alpha
Thursday, October 31, 2013 - 8:52am
tags:
Merrimack Pharmaceuticals, MM-121, ovarian cancer
Does The FDA Really Enforce A Conflicts Policy For Advisory Panels?
Pharmalot
Thursday, October 31, 2013 - 8:37am
tags:
FDA, advisory panels
Biotech IPOs: The Exit Challenge As Lockups Expire
Forbes
Thursday, October 31, 2013 - 8:34am
tags:
biotech, IPOs
Ariad suspends sales of blood cancer drug Iclusig
Reuters
Thursday, October 31, 2013 - 8:33am
tags:
Iclusig, Ariad Pharmaceuticals, FDA
AstraZeneca Profit Misses Estimates as Sales Decline
Bloomberg
Thursday, October 31, 2013 - 8:30am
tags:
AstraZeneca, earnings
J&J's Janssen Must Pay $4 Million Over Topamax, Jury Says
Bloomberg
Wednesday, October 30, 2013 - 8:45pm
tags:
Topamax, JNJ
Odds Favor Endocyte Receiving European Approval For Ovarian Cancer Drug
TheStreet.com
Wednesday, October 30, 2013 - 11:59am
tags:
Endocyte, Europe, ovarian cancer, vintafolide
AstraZeneca (AZN) Showing Signs Of Being Water-Logged And Getting Wetter
TheStreet.com
Wednesday, October 30, 2013 - 11:58am
tags:
AstraZeneca
Questcor Pharma shares sink after drugmaker updates analysts on government investigation
Yahoo/AP
Wednesday, October 30, 2013 - 10:45am
tags:
Questcor Pharmaceuticals
FDA bans suck sales out of Ranbaxy, Wockhardt
Fierce Pharma
Wednesday, October 30, 2013 - 10:38am
tags:
FDA, Ranbaxy, Wockhardt, India
Merck works toward bringing Zilmax back to U.S., Canada
Baltimore Sun, MD
Wednesday, October 30, 2013 - 10:36am
tags:
Merck, animal health, Zilmax

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.